Julia Van Der Hoven

Sydney, NSW 2109, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Intranasal delivery of Semaglutide using a thermoresponsive PNPHO nanocarrier: formulation development, characterization and biological evaluation.

Intranasal delivery of Semaglutide using a thermoresponsive PNPHO nanocarrier: formulation development, characterization and biological evaluation.

Journal: International journal of pharmaceutics

Published: July 16, 2026

Engineering a Novel Bacterial Encapsulin for Programmable Surface Functionalization: From Single-Target to Mosaic Nanovaccines.

Engineering a Novel Bacterial Encapsulin for Programmable Surface Functionalization: From Single-Target to Mosaic Nanovaccines.

Journal: bioRxiv : the preprint server for biology

Published: June 12, 2026

Engineering a Novel Bacterial Encapsulin for Programmable Surface Functionalization: From Single-Target to Mosaic Nanovaccines.

Engineering a Novel Bacterial Encapsulin for Programmable Surface Functionalization: From Single-Target to Mosaic Nanovaccines.

Journal: bioRxiv : the preprint server for biology

Published: June 12, 2026

Repurposing insulin for Alzheimer's disease treatment: intranasal delivery of a thermoresponsive nanocarrier-based insulin formulation to the brain.

Repurposing insulin for Alzheimer's disease treatment: intranasal delivery of a thermoresponsive nanocarrier-based insulin formulation to the brain.

Journal: Drug delivery and translational research

Published: December 01, 2025

Engineered Cyclotide Blocks Neuronal Excitotoxicity.

Engineered Cyclotide Blocks Neuronal Excitotoxicity.

Journal: Journal of medicinal chemistry

Published: December 04, 2024

Design of peptide therapeutics as protein-protein interaction inhibitors to treat neurodegenerative diseases.

Design of peptide therapeutics as protein-protein interaction inhibitors to treat neurodegenerative diseases.

Journal: RSC advances

Published: July 12, 2024

An overview of in vitro and in vivo techniques for characterization of intranasal protein and peptide formulations for brain targeting.

An overview of in vitro and in vivo techniques for characterization of intranasal protein and peptide formulations for brain targeting.

Journal: International journal of pharmaceutics

Published: December 07, 2023

Targeting 14-3-3θ-mediated TDP-43 pathology in amyotrophic lateral sclerosis and frontotemporal dementia mice.

Targeting 14-3-3θ-mediated TDP-43 pathology in amyotrophic lateral sclerosis and frontotemporal dementia mice.

Journal: Neuron

Published: August 08, 2023

Treatment of epilepsy using a targeted p38γ kinase gene therapy.

Treatment of epilepsy using a targeted p38γ kinase gene therapy.

Journal: Science advances

Published: December 02, 2022

TDP-43 pathology and functional deficits in wild-type and ALS/FTD mutant cyclin F mouse models.

TDP-43 pathology and functional deficits in wild-type and ALS/FTD mutant cyclin F mouse models.

Journal: Neuropathology and applied neurobiology

Published: October 31, 2022

Loss of LAMP5 interneurons drives neuronal network dysfunction in Alzheimer's disease.

Loss of LAMP5 interneurons drives neuronal network dysfunction in Alzheimer's disease.

Journal: Acta neuropathologica

Published: March 18, 2022

Rapid initiation of cell cycle reentry processes protects neurons from amyloid-β toxicity.

Rapid initiation of cell cycle reentry processes protects neurons from amyloid-β toxicity.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: March 19, 2021

Showing 1-12 of 25

Last Updated: 09/26/2026